Table 1.
Baseline Characteristics in the Total Cohort and by Treatment Arm
| OVERALL | TREATMENT GROUP |
||
|---|---|---|---|
| (N=902) | Self-Management (N=451) | Education (N=451) | |
| Demographics | |||
| Age, mean(sd) | 63.6 (13.5) | 63.8 (13.7) | 63.4 (13.3) |
| Female, N(%) | 427 (47.3) | 209 (46.3) | 218 (48.3) |
| Minority, N(%) | 362 (40.1) | 177 (39.2) | 185 (41.0) |
| ≤High School Education, N(%) | 394 (43.7) | 197 (43.7) | 197 (43.7) |
| Annual Family income < $30,000, N(%) | 428 (51.6) | 215 (51.9) | 213 (51.3) |
| Unmarried, N(%) | 503 (56.3) | 251 (56.3) | 252 (56.4) |
| Medical | |||
| Diastolic, N(%) | 208 (23.1) | 107 (23.8) | 101 (22.4) |
| NYHA Class III, N(%) | 285 (31.6) | 144 (31.9) | 141 (31.3) |
| 6-MinuteWalk(ft), md(iqr) | 843 (631.5) | 827 (610) | 880 (665) |
| Acute Physiology Score, mean(sd) | 2.6 (2.1) | 2.6 (2.0) | 2.6 (2.1) |
| History of Hypertension, N(%) | 676 (75.2) | 345 (76.8) | 331 (73.6) |
| History of Diabetes, N(%) | 362 (40.2) | 178 (39.6) | 184 (40.9) |
| Number of Co-Morbidities, mean(sd) | 3.2 (1.7) | 3.2 (1.7) | 3.3 (1.7) |
| Number of Medications, mean(sd) | 6.8 (3.0) | 6.8 (3.0) | 6.8 (3.0) |
| Current Use of, N(%) | |||
| Ace Inhibitor or ARB | 773 (85.7) | 383 (84.9) | 390 (86.5) |
| Beta Blocker | 636 (70.5) | 320 (71.0) | 316 (70.1) |
| Quality of Life: Physical Function, mean(sd)§ | 4.3 (1.0) | 4.3 (1.1) | 4.2 (1.0) |
| Adherence | |||
| Non-Adherence to Drug Therapy, N(%)* | 274 (36.5) | 143 (38.4) | 131 (34.6) |
| Salt Intake (mg/day), md(iqr) | 3338 (1619) | 3342 (1681) | 3309 (1558) |
| Current Smoker, N(%) | 85 (9.4) | 39 (8.6) | 46 (10.2) |
| Body Mass Index, mean(sd) | 31.0 (7.7) | 31.1 (7.3) | 30.9 (8.0) |
| Self-Efficacy at Self-Management, mean(sd)# | 7.6 (1.7) | 7.6 (1.8) | 7.6 (1.6) |
| Psychosocial | |||
| Major Depressive Symptoms, N(%) | 265 (29.4) | 136 (30.2) | 129 (28.7) |
| Social Support-Emotional, mean(sd)§ | 75.2 (22.2) | 74.3 (22.5) | 76.1 (21.9) |
| Purpose in Life, mean(sd)‡ | 4.5 (0.8) | 4.5 (0.8) | 4.5 (0.8) |
§
Range = 0–100 with higher score= greater quality of life or emotional support.
*
Non-Adherence = taking <80% of prescribed dose of ace inhibitor or beta blocker.
#
Range = 1–10 with higher score = greater self-efficacy.
‡
Range = 1–6 with higher score = greater life purpose.